Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Tanaka K, Ichikawa A, Umezawa N, Yamamoto K, Yoshifuji K, Okada K, Nogami A, Umezawa Y, Nagao T, Sakashita C, Mori T, Tohda S, Koike R, Yasuda S, Yamamoto M.
Tanaka K, et al. Among authors: yamamoto m, yamamoto k.
Cancer Sci. 2023 Sep;114(9):3719-3727. doi: 10.1111/cas.15894. Epub 2023 Jun 26.
Cancer Sci. 2023.
PMID: 37365854
Free PMC article.